Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Medtronic (NYSE:MDT) plans to spin off its Diabetes segment through an IPO of its subsidiary MiniMed Group, creating a standalone business focused on diabetes care. The company also received FDA ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...

FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...

Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth ...